CorreGene Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 8

CorreGene General Information

Description

Developer of a gene biotechnology designed to provide innovative therapies for solid tumors and chronic infections. The company utilizes a proprietary affinity optimization platform, TCR cloning, high-throughput discovery, process development, and analytical quality control, enabling the oncology and infectious disease markets to access targeted immunotherapy products for complex medical conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, North Building, Changfa International Precision Medicine Acceleration Center
  • Number 21, Xihuan Road, Life Science Park, Changping District
  • Beijing, 102206
  • China
+86 010
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 3rd Floor, North Building, Changfa International Precision Medicine Acceleration Center
  • Number 21, Xihuan Road, Life Science Park, Changping District
  • Beijing, 102206
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CorreGene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 20-May-2024 Completed Generating Revenue
3. Later Stage VC 01-Jul-2022 Completed Generating Revenue
2. Later Stage VC 02-Nov-2021 $15.6M $15.6M Completed Generating Revenue
1. Early Stage VC 01-Dec-2019 Completed Generating Revenue
To view CorreGene’s complete valuation and funding history, request access »

CorreGene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CorreGene Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ennovation Ventures Venture Capital Minority
Zhuhai Xinrui Medical Equity Investment Management Growth/Expansion Minority
CDBI Partners Venture Capital Minority
Chang Development Corporation Minority
Longmen Capital Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

CorreGene FAQs

  • When was CorreGene founded?

    CorreGene was founded in 2016.

  • Where is CorreGene headquartered?

    CorreGene is headquartered in Beijing, China.

  • What is the size of CorreGene?

    CorreGene has 16 total employees.

  • What industry is CorreGene in?

    CorreGene’s primary industry is Biotechnology.

  • Is CorreGene a private or public company?

    CorreGene is a Private company.

  • What is CorreGene’s current revenue?

    The current revenue for CorreGene is .

  • How much funding has CorreGene raised over time?

    CorreGene has raised $30.5M.

  • Who are CorreGene’s investors?

    Ennovation Ventures, Zhuhai Xinrui Medical Equity Investment Management, CDBI Partners, Chang Development, and Longmen Capital are 5 of 8 investors who have invested in CorreGene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process